Amylyx Pharmaceuticals, Inc. (AMLX) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 10 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for AMLX is $22.00, representing a +30.0% upside from the current price of $16.92. Price targets range from a low of $19.00 to a high of $28.00.
